Protagonist Therapeutics (PTGX) had the highest return between December 21, 2022 and March 15, 2023 by a mid-cap US stock, returning 157.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Protagonist Therapeutics (PTGX) | 12/21/2022 - 3/15/2023 | 157.22% |
Sotera Health (SHC) | 12/21/2022 - 3/15/2023 | 126.6% |
MoonLake Immunotherapeutics (MLTX) | 12/21/2022 - 3/15/2023 | 122.45% |
Iris Energy (IREN) | 12/21/2022 - 3/15/2023 | 94.29% |
iQIYI (IQ) | 12/21/2022 - 3/15/2023 | 93.3% |
Hut 8 Corp Common Stock (HUT) | 12/21/2022 - 3/15/2023 | 87.07% |
Marathon Digital (MARA) | 12/21/2022 - 3/15/2023 | 81.79% |
NeoGenomics (NEO) | 12/21/2022 - 3/15/2023 | 77.75% |
SoundHound AI (SOUN) | 12/21/2022 - 3/15/2023 | 74.53% |
Riot Blockchain (RIOT) | 12/21/2022 - 3/15/2023 | 74.22% |
Arlington Asset Investment (AI) | 12/21/2022 - 3/15/2023 | 73.75% |
BridgeBio Pharma (BBIO) | 12/21/2022 - 3/15/2023 | 70.45% |
TG Therapeutics (TGTX) | 12/21/2022 - 3/15/2023 | 70.39% |
Miniso Group Holding (MNSO) | 12/21/2022 - 3/15/2023 | 65.74% |
Alvotech (ALVO) | 12/21/2022 - 3/15/2023 | 64.13% |
Remitly Global (RELY) | 12/21/2022 - 3/15/2023 | 63.1% |
Ast Spacemobile (ASTS) | 12/21/2022 - 3/15/2023 | 61.33% |
Asana (ASAN) | 12/21/2022 - 3/15/2023 | 60.36% |
Intapp (INTA) | 12/21/2022 - 3/15/2023 | 59.95% |
Nuvei (NVEI) | 12/21/2022 - 3/15/2023 | 57.29% |
Oscar Health (OSCR) | 12/21/2022 - 3/15/2023 | 54.63% |
InterDigital (IDCC) | 12/21/2022 - 3/15/2023 | 53.62% |
Scotts Miracle-Gro (SMG) | 12/21/2022 - 3/15/2023 | 53.4% |
Axcelis Technologies (ACLS) | 12/21/2022 - 3/15/2023 | 52.12% |
Altair Engineering (ALTR) | 12/21/2022 - 3/15/2023 | 49.85% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
